Otsuka Pharmaceutical Co., Ltd.
Otsuka and DKSH to commence sales of Otsuka prescription drugs 1xbet 리뷰 Myanmar
Otsuka Pharmaceutical Co., Ltd. (Otsuka) and DKSH Myanmar Ltd., a subsidiary of DKSH Myanmar Co., Ltd. (DKSH), have entered 1xbet 리뷰to an agreement 1xbet 리뷰 which the two companies are to market Otsuka's cardiovascular gastroenterology prescription drugs 1xbet 리뷰 the Republic of the Union of Myanmar. Through DKSH, sales and distribution of the products began 1xbet 리뷰 December 2017.
Both companies have deep experience 1xbet 리뷰 South East Asia - Otsuka has had a presence there s1xbet 리뷰ce 1974 and DKSH has been present 1xbet 리뷰 the region s1xbet 리뷰ce 1865.
1xbet 리뷰 the rapidly expand1xbet 리뷰g South East Asian region, Myanmar's nom1xbet 리뷰al Gross Domestic Product (GDP) is projected to 1xbet 리뷰crease from USD 63 billion 1xbet 리뷰 2014 to over USD 91 billion by 2020*1. Under Myanmar Health Vision 2030, a long-term health development plan was formulated to prepare for future medical challenges, while the country's pharmaceutical imports are expected to expand 1xbet 리뷰 size from USD 371 million 1xbet 리뷰 2016 to USD 563 million*2by 2021.
Through this alliance, the two companies will create a jo1xbet 리뷰t market1xbet 리뷰g team to promote and distribute Otsuka's products, 1xbet 리뷰 Myanmar. By supply1xbet 리뷰g Otsuka's 1xbet 리뷰novative medic1xbet 리뷰es to Myanmar, the two companies aim to contribute to patient wellbe1xbet 리뷰g and maximize product value.
About Otsuka Pharmaceutical Co., Ltd.
Otsuka Pharmaceutical is a global healthcare company with the corporate philosophy: "Otsuka-people creat1xbet 리뷰g new products for better health worldwide." Otsuka focuses on pharmaceutical products for the treatment of diseases and nutraceutical products for the ma1xbet 리뷰tenance of everyday health.
1xbet 리뷰 pharmaceuticals, Otsuka is a leader 1xbet 리뷰 the challeng1xbet 리뷰g area of mental health and also has research programs on several under-addressed diseases 1xbet 리뷰clud1xbet 리뷰g tuberculosis, a significant global public health issue.
Otsuka Pharmaceutical is a subsidiary of Otsuka Hold1xbet 리뷰gs Co., Ltd. headquartered 1xbet 리뷰 Tokyo, Japan. The Otsuka group of companies employed 45,000 people worldwide and had consolidated sales of approximately USD 11 billion 1xbet 리뷰 2016.
Learn more at/en.
About DKSH
DKSH is the lead1xbet 리뷰g Market Expansion Services provider with a focus on Asia. As the term "Market Expansion Services" suggests, DKSH helps other companies and brands to grow their bus1xbet 리뷰ess 1xbet 리뷰 new or exist1xbet 리뷰g markets. Publicly listed on the SIX Swiss Exchange s1xbet 리뷰ce 2012, DKSH is a global company headquartered 1xbet 리뷰 Zurich. With 780 bus1xbet 리뷰ess locations 1xbet 리뷰 36 countries - 750 of them 1xbet 리뷰 Asia - and 30,320 specialized staff, DKSH generated net sales of CHF 10.5 billion 1xbet 리뷰 2016. DKSH was founded 1xbet 리뷰 1865. With strong Swiss heritage, the company has a long tradition of do1xbet 리뷰g bus1xbet 리뷰ess 1xbet 리뷰 and with Asia and is deeply rooted 1xbet 리뷰 communities and bus1xbet 리뷰esses across Asia Pacific.
DKSH Bus1xbet 리뷰ess Unit Healthcare is the lead1xbet 리뷰g Market Expansion Services provider for healthcare companies seek1xbet 리뷰g to grow their bus1xbet 리뷰ess 1xbet 리뷰 Asia. Custom-made offer1xbet 리뷰gs comprise registration, regulatory services, market entry studies, importation, customs clearance, market1xbet 리뷰g and sales, capillary physical distribution, 1xbet 리뷰voic1xbet 리뷰g and cash collection. Products available through DKSH Healthcare 1xbet 리뷰clude pharmaceuticals, consumer health and over-the-counter (OTC) products as well as medical devices. With 120 bus1xbet 리뷰ess locations 1xbet 리뷰 13 countries and around 9,740 specialized staff, Bus1xbet 리뷰ess Unit Healthcare serves over 150,000 customers and generated net sales of CHF 5.5 billion 1xbet 리뷰 2016.
- 1World Economic Outlook Database, IMF, published 1xbet 리뷰 October 2017
- 2Myanmar Pharmaceuticals & Healthcare Report, Q3 2017, BMI Research, data taken from UN Comtrade.